The University of Chicago Header Logo

Connection

James Liao to Stroke

Back to Details
This is a "connection" page, showing publications James Liao has written about Stroke.
James Liao
Connection Strength
4.173
Stroke
  1. The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia. Curr Vasc Pharmacol. 2019; 17(3):222-232.
    View in: PubMed
    Score: 0.378
  2. ROCK as a therapeutic target for ischemic stroke. Expert Rev Neurother. 2017 Dec; 17(12):1167-1177.
    View in: PubMed
    Score: 0.349
  3. Relative Lack of Culprit and Obstructive Coronary Lesions in Patients With Acute Ischemic Stroke and Elevated Cardiac Troponin. Circulation. 2016 Mar 29; 133(13):1228-9.
    View in: PubMed
    Score: 0.311
  4. Gene variations of ROCKs and risk of ischaemic stroke: the Women's Genome Health Study. Clin Sci (Lond). 2014 Jun; 126(12):829-835.
    View in: PubMed
    Score: 0.275
  5. Potential serum biomarkers in the pathophysiological processes of stroke. Expert Rev Neurother. 2014 Feb; 14(2):173-85.
    View in: PubMed
    Score: 0.268
  6. ROCKs as immunomodulators of stroke. Expert Opin Ther Targets. 2012 Oct; 16(10):1013-25.
    View in: PubMed
    Score: 0.244
  7. NF-?B and innate immunity in ischemic stroke. Ann N Y Acad Sci. 2010 Oct; 1207:32-40.
    View in: PubMed
    Score: 0.214
  8. Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protection. Expert Rev Neurother. 2009 Aug; 9(8):1171-86.
    View in: PubMed
    Score: 0.197
  9. Increased leukocyte ROCK activity in patients after acute ischemic stroke. Brain Res. 2009 Feb 27; 1257:89-93.
    View in: PubMed
    Score: 0.189
  10. Additive effects of statin and dipyridamole on cerebral blood flow and stroke protection. J Cereb Blood Flow Metab. 2008 Jul; 28(7):1285-93.
    View in: PubMed
    Score: 0.180
  11. Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol. 2008 Mar; 28(3):s39-42.
    View in: PubMed
    Score: 0.177
  12. Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer? Circulation. 2007 Mar 27; 115(12):1615-21.
    View in: PubMed
    Score: 0.167
  13. Drug Insight: statins and stroke. Nat Clin Pract Cardiovasc Med. 2005 Nov; 2(11):576-84.
    View in: PubMed
    Score: 0.152
  14. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke. 2005 Oct; 36(10):2251-7.
    View in: PubMed
    Score: 0.150
  15. Role of statin pleiotropism in acute coronary syndromes and stroke. Int J Clin Pract Suppl. 2003 Mar; (134):51-7.
    View in: PubMed
    Score: 0.126
  16. Rapid effects of statins: from prophylaxis to therapy for ischemic stroke. Arterioscler Thromb Vasc Biol. 2003 Feb 01; 23(2):156-7.
    View in: PubMed
    Score: 0.126
  17. Statins and ischemic stroke. Atheroscler Suppl. 2002 May; 3(1):21-5.
    View in: PubMed
    Score: 0.119
  18. Decreased thromboembolic stroke but not atherosclerosis or vascular remodelling in mice with ROCK2-deficient platelets. Cardiovasc Res. 2017 Sep 01; 113(11):1307-1317.
    View in: PubMed
    Score: 0.086
  19. Rho-associated kinase activity is an independent predictor of cardiovascular events in acute coronary syndrome. Hypertension. 2015 Oct; 66(4):892-9.
    View in: PubMed
    Score: 0.075
  20. Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol. 2011 Jan; 69(1):119-29.
    View in: PubMed
    Score: 0.054
  21. Elevated homocysteine and C-reactive protein levels independently predict worsening prognosis after stroke in Chinese patients. J Huazhong Univ Sci Technolog Med Sci. 2010 Oct; 30(5):643-7.
    View in: PubMed
    Score: 0.054
  22. Novel aspects of the roles of Rac1 GTPase in the cardiovascular system. Curr Opin Pharmacol. 2010 Apr; 10(2):116-21.
    View in: PubMed
    Score: 0.051
  23. Linking Notch signaling to ischemic stroke. Proc Natl Acad Sci U S A. 2008 Mar 25; 105(12):4856-61.
    View in: PubMed
    Score: 0.045
  24. Targeting eNOS for stroke protection. Trends Neurosci. 2004 May; 27(5):283-9.
    View in: PubMed
    Score: 0.034
  25. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest. 2002 Dec; 110(11):1729-38.
    View in: PubMed
    Score: 0.031
  26. Beyond lipid lowering: the role of statins in vascular protection. Int J Cardiol. 2002 Nov; 86(1):5-18.
    View in: PubMed
    Score: 0.031
  27. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol. 2001 Nov; 21(11):1712-9.
    View in: PubMed
    Score: 0.029
  28. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke. 2001 Apr; 32(4):980-6.
    View in: PubMed
    Score: 0.028
  29. Direct vascular effects of HMG-CoA reductase inhibitors. Trends Cardiovasc Med. 2000 May; 10(4):143-8.
    View in: PubMed
    Score: 0.026
  30. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab. 2005 Jun; 25(6):722-9.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.